Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vericel Corporation (NQ: VCEL ) 43.36 +2.01 (+4.86%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 289,431 Open 42.04 Bid (Size) 43.35 (1) Ask (Size) 46.31 (1) Prev. Close 41.35 Today's Range 41.86 - 43.58 52wk Range 30.18 - 54.10 Shares Outstanding 46,631,158 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024 August 29, 2024 From Vericel Corporation Via GlobeNewswire The Analyst Verdict: Vericel In The Eyes Of 7 Experts August 27, 2024 Via Benzinga Performance YTD +24.31% +24.31% 1 Month -11.58% -11.58% 3 Month -7.11% -7.11% 6 Month -14.00% -14.00% 1 Year +27.75% +27.75% More News Read More Vericel Announces FDA Approval and Commercial Availability of MACI Arthro August 26, 2024 From Vericel Corporation Via GlobeNewswire Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns August 15, 2024 From Vericel Corporation Via GlobeNewswire Expert Ratings For Vericel August 09, 2024 Via Benzinga The Latest Analyst Ratings For Vericel August 02, 2024 Via Benzinga A Glimpse Into The Expert Outlook On Vericel Through 4 Analysts July 16, 2024 Via Benzinga Critical Insights From Vericel Analyst Ratings: What You Need To Know May 09, 2024 Via Benzinga Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024 August 07, 2024 From Vericel Corporation Via GlobeNewswire Apple To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Friday August 02, 2024 Via Benzinga Vericel Reports Second Quarter 2024 Financial Results August 01, 2024 From Vericel Corporation Via GlobeNewswire Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer July 22, 2024 From Vericel Corporation Via GlobeNewswire Analyst Scoreboard: 5 Ratings For Vericel March 26, 2024 Via Benzinga A Closer Look at 4 Analyst Recommendations For Vericel March 01, 2024 Via Benzinga Earnings Scheduled For February 29, 2024 February 29, 2024 Via Benzinga Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024 July 18, 2024 From Vericel Corporation Via GlobeNewswire Trading SMID Biotech Stocks In A Volatile Market July 01, 2024 Via Talk Markets The 3 Highest-Rated Medical Stocks You Can Buy Today June 27, 2024 Via InvestorPlace Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024 June 11, 2024 From Vericel Corporation Via GlobeNewswire Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024 May 22, 2024 From Vericel Corporation Via GlobeNewswire VCEL Stock Earnings: Vericel Beats EPS, Beats Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance May 08, 2024 From Vericel Corporation Via GlobeNewswire Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024 April 24, 2024 From Vericel Corporation Via GlobeNewswire It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility March 11, 2024 Via Talk Markets Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance February 29, 2024 From Vericel Corporation Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
